Safety and Efficacy of RAD001 in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor

NCT01324492 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Neuroendocrine Neoplasm

Interventions

DRUG: RAD001

Sponsor

Novartis Pharmaceuticals